Imatinib induces autophagy through BECLIN‐1 and ATG5 genes in chronic myeloid leukemia cells

References

• Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96:3343–56.
   PubMed Web of Science ®Google Scholar
• Peled A, Hardan I, Trakhtenbrot L, Gur E, Magid M, Darash-Yahana M, et al.. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Stem Cells 2002;20:259–66.
   PubMed Web of Science ®Google Scholar
• Koca E, Haznedaroglu IC. Imatinib mesylate and the management of chronic myeloid leukemia (CML). Turk J Hematol 2005;2(4):161–72.
   Google Scholar
• Ertmer A, Huber V, Gilch S, Yoshimori T, Erfle V, Duyster J, et al.. The anticancer drug imatinib induces cellular autophagy. Leukemia 2007;21:936–42.
   PubMed Web of Science ®Google Scholar
• Frame D. New strategies in controlling drug resistance. J Manag Care Pharm 2007;13:13–7.
   PubMed Web of Science ®Google Scholar
• Baran Y, Ural AU, Gunduz U. Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Hematology 2007;12:497–503.
   PubMed Web of Science ®Google Scholar
• Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, et al.. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem 2007;282:10922–34.
   PubMed Web of Science ®Google Scholar
• Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004;306:990–5.
   PubMed Web of Science ®Google Scholar
• Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008;90:313–23.
   PubMed Web of Science ®Google Scholar
• Kawamata T, Kamada Y, Kabeya Y, Sekito T, Ohsumi Y. Organization of the pre-autophagosomal structure responsible for autophagosome formation. Mol Biol Cell 2008;19:2039–50.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, et al.. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001;152:657–68.
   PubMed Web of Science ®Google Scholar
• Kametaka S, Matsuura A, Wada Y, Ohsumi Y. Structural and functional analyses of APG5, a gene involved in autophagy in yeast. Gene 1996;178:139–43.
   PubMed Web of Science ®Google Scholar
• Kametaka S, Okano T, Ohsumi M, Ohsumi Y. Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae. J Biol Chem 1998;273:22284–91.
   PubMed Web of Science ®Google Scholar
• Kihara A, Noda T, Ishihara N, Ohsumi Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol 2001;152:519–30.
   PubMed Web of Science ®Google Scholar
• He H, Dang Y, Dai F, Guo Z, Wu J, She X, et al.. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 2003;278:29278–87.
   PubMed Web of Science ®Google Scholar
• Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol 2007;8:622–32.
   PubMed Web of Science ®Google Scholar
• Mijaljica D, Prescott M, Klionsky DJ, Devenish RJ. Autophagy and vacuole homeostasis: a case for self-degradation? Autophagy 2007;3:417–21.
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen GH, et al.. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006;10:51–64.
   PubMed Web of Science ®Google Scholar
• Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007;14:500–10.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Yu DN, Lum JJ, Bui T, Christophorou MA, Evan GI, et al.. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007;117:326–36.
   PubMed Web of Science ®Google Scholar
• Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008;3:427–55.
   PubMed Web of Science ®Google Scholar
• Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009;1792:3–13.
   PubMed Web of Science ®Google Scholar
• Gucluler G, Baran Y. Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells. Hematology, 2009;14(3):139–44.
   PubMed Web of Science ®Google Scholar
• Ogier-Denis E, Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 2003;1603:113–28.
   PubMed Web of Science ®Google Scholar
• Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004;23:2891–906.
   PubMed Web of Science ®Google Scholar
• Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, et al.. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999;59:59–65.
   PubMed Web of Science ®Google Scholar
• Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, et al.. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001;276:35243–6.
   PubMed Web of Science ®Google Scholar
• Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al.. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001;61:439–44.
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol 2004;14:70–7.
   PubMed Web of Science ®Google Scholar
• Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al.. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80.
   PubMed Web of Science ®Google Scholar
• Matei D, Chang DD, Jeng MH. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation. Clin Cancer Res 2004;10:681–90.
   PubMed Web of Science ®Google Scholar
• Fiorentini G, Rossi S, Lanzanova G, Biancalani M, Palomba A, Bernardeschi P, et al.. Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial. J Exp Clin Cancer Res 2003;22:17–20.
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit B, Horsch D, Barth P, Arnold R, Blocker S, Goke R. Effects of the tyrosine kinase inhibitor imatinib on neuroendocrine tumor cell growth. Digestion 2005;71:131–40.
   PubMed Web of Science ®Google Scholar
• Mor-Tzuntz R, Uziel O, Shpilberg O, Lahav J, Raanani P, Bakhanashvili M, et al.. Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib. Exp Hematol 2010;38:27–37.
   PubMed Web of Science ®Google Scholar
• Bonhoure E, Lauret A, Barnes DJ, Martin C, Malavaud B, Kohama T, et al.. Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia 2008;22:971–9.
   PubMed Web of Science ®Google Scholar